UUID: 631368E3- 4C23- 4337- 9698- -1EAED43R5525Da
TCGA-— CF- A9FF- -01A- PR

Ill llllllllllllllllllllllllllllllllllllllllllllllllllllllilliillllcllm
Ill lllHIll l|I||||IlllllIlllllllllllllllllll llllllllllllllll lllllll

Clinical Case Report (54/ 26:?) 0- 3 .
(For Collection of Cancerous Tissue) claw. Hawk Vii-ELL :2?
4‘

MW
Wm an;

0216‘ 1”),sz {70171.0 17 M1931; Via":
aw) 3/3013 —
Informed Consen- . Wt t/ﬂ‘uy‘ﬁ,‘ mﬁwt Luau

(’0
I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I Ieviewed the RESEARCH SUBJECT INFORMATION AND CONSENT ‘ y, ///""//‘7’
FORM with the patient and answered any questions the patient had. The patient then signed the

consent form as a free and voluntary act A copy of this informed consent document will be retained at
our institution.

 

 

 

 

u_‘.

Name of Physician or Study Coordinator signature Date

 

lglinical Informatioﬁ

of Birth Marital

Race
El Single Married

Gender El Divorced U Widow Blood Pressure Heart Rate
ale [3 Female - V -

 

  

" ~ IIIHISTORY 0F PRESENMLLNESSI “ ;
ChIefComplaInts- Lou/m MWMM [Damon J bfawi WT‘Ka W *

Symptoms: “lg/{W {93; _ I I

Clinical Findings:

 

 

 

 

 

Performance Scale (Karnofsky Score):

E] 100 Asymptomatic El 80- 9O Symptomatic but Fully Ambulatory FW- -70 Symptomatic, in bed less than 50% of day
El 40- 50 Symptomatic in bed more than 50% of day, but no bed ridden [J 20 30 Bed Ridden

 

 

 

MEDI . 0 S 5,
Route

 

"I w" a»: 3,", I ,l'

H , a ._ i P . v ' *2 . RY '3?”
nosis Disease Disorder

Treatment

 

   

 

     

 

Menopausal Status
[3 Pre-menopausal
CI Peri-Menopausal
U Post-menopausal

Date of First Menses # of Pregnancies

 

 

 

Date of Last Menses # of Live Births

 

 

 

Birth Control: D Condom D Oral Contraceptive I: IUD

c1 Hormone Replacement
D Other:

Therapy:

 

 

 

 

Environmental Hazards:
Smoki H

Packs Duration

Alcohol Consum

TYPE Drinks

Duration
YES a N0 ‘

Use
Current Status

Duration
El YES NO

“'53
t'.

 

 

 
       
  

Test Result
HIV _ 'Ia’Negative D Positive:

Hep B (pNegative El Positive: '
Hep C @NegaLive El Positive:
AFP 'Cl Iiegajve El Positive:

Other:

 

Result
D Negajve CI Positive:
El Negative ' I:I Positive:
D 1% El Positive:
[1 Negative El Positive:

 

 

 

 

 

 

 

 

E1 Negative El Positive:
B/T Cell Markers:

 

U Negative El Positive:

 

 

 

 

 

 

 

 

 

Ultrasound
x-
CT
Endosco
MRI

Clinical
Location of Involved L Nodes Location of Distant Metastasis

Clinical Date of
T Z N 0 M 0 Stage: 11;

 

 

l'ljeatment Informationl

1. GICAL * I;
Procedure Date Procedure

Prima Tumor
Detailed Location Size

Extension of umor

L Nodes

Descri of L Nodes # of L Nodes
Palpable, Non-Dissected Lymph Nodes

Dissected Lymph Nodes
Distant Metastasis

Detailed Location

ical Sta
M

 

Collected by: __
Preserved by:

, 'E-l‘i,_t(i{1"'i

Frozen
Diseased

Time to LN2

Notes:

Normal

min

' “We“ ill-A

 

,, a, Date: _

Pathology Form

 

[Specimen Information!

Time:

7..”—

_ Date: . _Time:_

Biood/Serum/Plasma Slide
Diseased Normal Diseased

Parafﬁn Block
Diseased Normal

Z

Time to Formalin

Normal

Time to LN2

Prima Tumor
Size Extension of Tumor Distance to NAT
x/ "‘cm ‘ cm

Nodes

# Examined # Metastasized a;

DistantMetastasis
Detailed Location

 

 

 

 

Consolidated Pathology Diagnosis
1”:

 

 

 

 

 

 

 

 

 

——-____.

Director, Research Pathology D.”

   

INTEGRATED REPORT OF FINDINGS BY COLLABORATORS AND PATHOLOGISTS - F 1w ( 3 I

Case
l Reviewer

 

